These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10455428)

  • 21. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
    Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I
    Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular therapy in support to radiotherapy.
    Dutreix M; Cosset JM; Sun JS
    Mutat Res; 2010; 704(1-3):182-9. PubMed ID: 20067843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
    Li Y; Li W; Yang Y; Lu Y; He C; Hu G; Liu H; Chen J; He J; Yu H
    Brain Res; 2009 Aug; 1286():13-8. PubMed ID: 19559015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-angiogenic strategies for cancer therapy (Review).
    Benouchan M; Colombo BM
    Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
    Bonavida B; Vega MI
    Drug Resist Updat; 2005; 8(1-2):27-41. PubMed ID: 15939340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy to overcome drug resistance in cancer: targeting key regulators of the apoptotic pathway.
    Piché A; Rancourt C
    Curr Gene Ther; 2001 Nov; 1(4):317-24. PubMed ID: 12109059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for reversing drug resistance.
    Fojo T; Bates S
    Oncogene; 2003 Oct; 22(47):7512-23. PubMed ID: 14576855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug resistance.
    Funato T
    Methods Mol Med; 2005; 106():215-33. PubMed ID: 15375319
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antisense oligonucleotides arrest the synthesis of disease promoting proteins].
    Schnädelbach S
    Med Monatsschr Pharm; 1998 Dec; 21(12):394-5. PubMed ID: 9925458
    [No Abstract]   [Full Text] [Related]  

  • 30. Application of ribozymes to cancer gene therapy.
    Kashani-Sabet M; Scanlon KJ
    Cancer Gene Ther; 1995 Sep; 2(3):213-23. PubMed ID: 8528965
    [No Abstract]   [Full Text] [Related]  

  • 31. 10th International Conference on gene therapy of cancer: 13 - 15 December 2001, San Diego, CA, USA.
    Chen Y
    Expert Opin Biol Ther; 2002 Apr; 2(4):443-5. PubMed ID: 11955281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of tumor cell apoptosis and chemosensitization by antisense strategies.
    Rieber M; Strasberg-Rieber M
    Methods Mol Med; 2005; 106():205-14. PubMed ID: 15375318
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intracellular antibodies: a new therapeutic concept for virus infections and neoplasms].
    zu Putlitz J; Blum HE
    Dtsch Med Wochenschr; 1999 Mar; 124(12):357-60. PubMed ID: 10214369
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor chemosensitization strategies based on apoptosis manipulations.
    Shabbits JA; Hu Y; Mayer LD
    Mol Cancer Ther; 2003 Aug; 2(8):805-13. PubMed ID: 12939471
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene therapy for HIV infections: Intracellular immunization.
    Piché A
    Can J Infect Dis; 1999 Jul; 10(4):307-12. PubMed ID: 22346390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lettsomian Lecture. Selective cancer therapy: is it attainable with engineered antibodies and gene therapy?
    Begent RH
    Trans Med Soc Lond; 1996-1997; 113():51-6. PubMed ID: 10326088
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetically engineered intracellular single-chain antibodies in gene therapy.
    Bilbao G; Contreras JL; Curiel DT
    Mol Biotechnol; 2002 Oct; 22(2):191-211. PubMed ID: 12405266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of human cancer by immunologic methods.
    Goldstein G; Horsley JS
    Va Med Mon (1918); 1971 Feb; 98(2):100-5. PubMed ID: 5549322
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.
    Byrne D; Daly C; Nicamhlaoibh R; Howlett A; Scanlon K; Clynes M
    Cytotechnology; 1998 Sep; 27(1-3):113-36. PubMed ID: 19002787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: perspectives on strategies for overcoming cancer therapy resistance.
    Wu Z; Han W
    Curr Protein Pept Sci; 2015; 16(4):268-9. PubMed ID: 25929860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.